Onelar (Duloxetine)

Duloxetine, the active ingredient in Onelar, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as a strength‑form for oral use. It is indicated for several mood‑related and pain conditions in adults. GNH USA supplies Onelar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Onelar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Duloxetine acts on neurotransmitter pathways that influence mood and pain perception.

- Major depressive disorder: alleviates depressive symptoms and improves functional outcomes. - Generalized anxiety disorder: reduces anxiety levels and associated physical symptoms. - Diabetic peripheral neuropathic pain: lessens pain intensity and improves quality of life. - Fibromyalgia: decreases widespread musculoskeletal pain and fatigue. - Chronic musculoskeletal pain: provides relief from chronic lower‑back and osteoarthritis pain.

Duloxetine may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dry mouth: reduced salivation. - Headache: transient cranial pain. - Sweating: increased perspiration. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Hypertensive crisis: sudden, severe increase in blood pressure. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence or worsening of suicidal ideation. - Orthostatic hypotension: marked drop in blood pressure upon standing.

When prescribing Duloxetine, clinicians should evaluate patient history and monitor for specific safety concerns.

- Liver function: assess baseline enzymes and monitor periodically. - Blood pressure: check regularly, especially in patients with hypertension. - Suicide risk: monitor mood changes, particularly at treatment initiation. - Drug discontinuation: taper gradually to avoid discontinuation syndrome. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Duloxetine can interact with several drug classes, requiring careful review of a patient’s medication list.

Major Interactions (Avoid): - MAO inhibitors: risk of serotonin syndrome; a 14‑day washout is required. - SSRIs/SNRIs: additive serotonergic effect may precipitate serotonin syndrome. - Strong CYP1A2 inhibitors (e.g., fluvoxamine): increase duloxetine plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs and antiplatelet agents: heightened bleeding risk. - Antihypertensives: possible attenuation of blood‑pressure‑lowering effect. - CYP2D6 substrates (e.g., metoprolol): duloxetine may raise their concentrations.